Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05231512 · ClinicalTrials.gov registry record · NA

The Effects of a Music Therapy Respiratory Protocol on Post-Covid-19 Respiratory Symptoms

A NA study, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
33
Enrollment target

NCT05231512 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 33 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05231512, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target

Study Summary

The effects of a tested and published music therapy respiratory protocol shown to be efficacious with pediatric asthma and adult COPD is being studied with individuals living with post-Covid-19 respiratory symptoms. An interventional, single arm study is being conducted with individuals meeting eligibility criteria detailed below. Primary outcome is a change in the MRC Dyspnea score, with secondary aims focusing on improved quality of life, including reduced fatigue and depression and improved sleep and resilience.

Interventions

  • OTHER Respiratory Music Therapy Protocol

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2022-01-13
Est. Completion 2023-03-13
Phase NA

What the Registry Record Tells You About NCT05231512

The ClinicalTrials.gov registry entry for NCT05231512 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Respiratory Music Therapy Protocol is the first listed.

NCT05231512 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05231512 about?

NCT05231512 is a clinical study titled "The Effects of a Music Therapy Respiratory Protocol on Post-Covid-19 Respiratory Symptoms". The effects of a tested and published music therapy respiratory protocol shown to be efficacious with pediatric asthma and adult COPD is being studied with individuals living with post-Covid-19 respiratory symptoms. An interventional, single arm study is being conducted with individuals meeting elig...

What is the current status of trial NCT05231512?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2022-01-13. Estimated completion is 2023-03-13.

What interventions are being tested in trial NCT05231512?

The interventions under investigation include: Respiratory Music Therapy Protocol (OTHER).

Who is sponsoring clinical trial NCT05231512?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.